<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Oramed Subsidiary Oravax Announces First Participant Enrolled in Phase 1 Oral COVID-19 Vaccine Trial in South Africa	</title>
	<atom:link href="https://ora-vax.com/press-releases/oramed-subsidiary-oravax-announces-first-participant-enrolled-in-phase-1-oral-covid-19-vaccine-trial-in-south-africa/feed/" rel="self" type="application/rss+xml" />
	<link>https://ora-vax.com/press-releases/oramed-subsidiary-oravax-announces-first-participant-enrolled-in-phase-1-oral-covid-19-vaccine-trial-in-south-africa/</link>
	<description>Oravax is developing breakthrough technologies for the oral delivery of vaccines</description>
	<lastBuildDate>Tue, 28 Dec 2021 11:56:58 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.9.9</generator>
</channel>
</rss>
